40. Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM: Efficacy and safety ofcombination therapy: Repaglinide plus metforminversus nateglinide plus metformin. Diabetes Care2003;26:2063–2068. 41. Gomez-Perez FJ, Fanghanel-Salmon G, Antonio Bar- bosa J, Montes-Villarreal J, Berry RA, Warsi G, GouldEM: Efficacy and safety of rosiglitazone plus met-formin in Mexicans with type 2 diabetes. DiabetesMetab Res Rev 2002;18:127–134. 42. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI: Efficacy and metabolic effectsof metformin and troglitazone in type II diabetes mel-litus. N Engl J Med 1998;338:867–872. 43. Rosenstock J, Brown A, Fischer J, Jain A, Littlejohn T, Nadeau D, Sussman A, Taylor T, Krol A, Magner J:POON ET AL. 4765678_05_p467-477  5/18/05  12:44 PM  Page 476